EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Clinical trial NCT03266653 · RECRUITING

Trial details

NCT number: NCT03266653
Sponsor: New York Medical College
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epstein-Barr Virus Infections Primary Immune Deficiency Disorder

Start date: 2020-07-07
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.